Last quarter (Q3 2025), AC Immune SA's total revenue was CHF939.00K, a decrease of -96.32% from the same quarter last year. In Q3, AC Immune SA's net income was CHF-15.86M. See AC Immune SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	CHF 27.31M	CHF 14.80M	CHF 3.94M	CHF 0.00	CHF 15.43M
Gross Profit	CHF -35.26M	CHF -39.80M	CHF 3.94M	CHF 0.00	CHF -44.06M
Operating Expenses	CHF 17.12M	CHF 13.82M	CHF 74.78M	CHF 79.01M	CHF 17.20M
Depreciation and Amortization	CHF 2.16M	CHF 2.21M	CHF 2.36M	CHF 2.41M	CHF 1.53M
EBITDA	CHF -48.62M	CHF -51.83M	CHF -68.03M	CHF -70.01M	CHF -59.73M
Operating Income	CHF -52.38M	CHF -53.62M	CHF -70.85M	CHF -79.01M	CHF -61.26M
Other Income/Expenses	CHF 1.47M	CHF -599.00K	CHF 107.00K	CHF 6.02M	CHF -661.00K
Pretax Income	CHF -50.91M	CHF -54.22M	CHF -70.74M	CHF -72.99M	CHF -61.92M
Net Income	CHF -50.92M	CHF -54.23M	CHF -70.75M	CHF -73.00M	CHF -61.92M
Per Share Metrics
Basic EPS	CHF -0.51	CHF -0.64	CHF -0.85	CHF -0.97	CHF -0.86
Diluted EPS	CHF -0.51	CHF -0.64	CHF -0.85	CHF -0.97	CHF -0.86
Weighted Average Shares Outstanding	99.69M	84.69M	83.55M	74.95M	71.90M
Weighted Average Shares Outstanding (Diluted)	99.69M	84.69M	83.55M	74.95M	71.90M

Currency in CHF

AC Immune SA Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing